Cite
MLA Citation
M. Ducreux et al.. “2131 Efficacy and safety of nab-paclitaxel (nab-P) in patients (pts) with previously treated metastatic colorectal cancer (mCRC): The phase II COLO-001 trial.” European journal of cancer, vol. 51, n.d., pp. S376–. http://access.bl.uk/ark:/81055/vdc_100030628213.0x000057